Leniolisib Phosphate

CHEMBL3989909 Phase 4 已批准 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

548.5 g/mol

LogP

—

Phase

4

The phosphate salt form of leniolisib, a PI3K-delta inhibitor studied for treating primary immunodeficiency disorders. It shares the same targeted mechanism as the parent compound.

分子量

548.5000 g/mol

TPSA

161.00 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

二维结构

SVG PNG

Cite this structure

Embed this structure

SMILES

CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1.O=P(O)(O)O

InChI

InChI=1S/C21H25F3N6O2.H3O4P/c1-3-18(31)30-6-4-13(10-30)28-19-15-11-29(7-5-17(15)26-12-27-19)14-8-16(21(22,23)24)20(32-2)25-9-14;1-5(2,3)4/h8-9,12-13H,3-7,10-11H2,1-2H3,(H,26,27,28);(H3,1,2,3,4)/t13-;/m0./s1

Molecular Formula

C21H28F3N6O6P

HBD / HBA

4 / 14

可旋转键数

5

重原子数

37

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

The phosphate salt form of leniolisib, a PI3K-delta inhibitor studied for treating primary immunodeficiency disorders. It shares the same targeted mechanism as the parent compound.

Yes, Leniolisib Phosphate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989909. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 90214495. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

正在寻找患者友好型信息？

Leniolisib Phosphate 在 PillFYI 上

结构

快速数据

分子式: C21H28F3N6O6P

外部链接

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.